Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celeghini

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Physical Review Letters|April 22, 1991
Squeezing and quantum groupsCeleghini, Rasetti, Vitiello
Journal of Leukocyte Biology|June 4, 2008
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL)Federica Corallini, Claudio Celeghini
Physical Review. B, Condensed Matter|September 1, 1992
Quantum Galilei group as symmetry of magnonsBonechi, Celeghini, Giachetti, et al.
Physical Review Letters|June 22, 1992
Inhomogeneous quantum groups as symmetries of phononsBonechi, Celeghini, Giachetti, et al.
European Journal of Histochemistry : EJH|May 27, 2008
Effect of recombinant TRAIL in a murine co-culture system of osteoclastogenesisV Nicolin, P Narducci, C Celeghini
Current Pharmaceutical Design|March 12, 2011
Recent advances in the therapeutic perspectives of Nutlin-3Paola Secchiero, Raffaella Bosco, Claudio Celeghini, et al.
Atherosclerosis|March 28, 2007
Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitusClaudio Celeghini, Roberta Bortul, Roberto Fadda, et al.
Entropy (Basel, Switzerland)|December 3, 2020
Hermite Functions, Lie Groups and Fourier AnalysisEnrico Celeghini, Manuel Gadella, Mariano A Del Olmo
Current Medicinal Chemistry|September 14, 2017
Repositioning of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into PracticeAnnalisa Marcuzzi, Claudia Loganes, Claudio Celeghini, et al.
Cellular and Molecular Life Sciences : CMLS|January 15, 2014
NF-κB pathways in hematological malignanciesChiara Gasparini, Claudio Celeghini, Lorenzo Monasta, et al.
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Physical Review Letters|April 22, 1991
Squeezing and quantum groupsCeleghini, Rasetti, Vitiello
Journal of Leukocyte Biology|June 4, 2008
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL)Federica Corallini, Claudio Celeghini
Physical Review. B, Condensed Matter|September 1, 1992
Quantum Galilei group as symmetry of magnonsBonechi, Celeghini, Giachetti, et al.
Physical Review Letters|June 22, 1992
Inhomogeneous quantum groups as symmetries of phononsBonechi, Celeghini, Giachetti, et al.
European Journal of Histochemistry : EJH|May 27, 2008
Effect of recombinant TRAIL in a murine co-culture system of osteoclastogenesisV Nicolin, P Narducci, C Celeghini
Current Pharmaceutical Design|March 12, 2011
Recent advances in the therapeutic perspectives of Nutlin-3Paola Secchiero, Raffaella Bosco, Claudio Celeghini, et al.
Atherosclerosis|March 28, 2007
Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitusClaudio Celeghini, Roberta Bortul, Roberto Fadda, et al.
Entropy (Basel, Switzerland)|December 3, 2020
Hermite Functions, Lie Groups and Fourier AnalysisEnrico Celeghini, Manuel Gadella, Mariano A Del Olmo
Current Medicinal Chemistry|September 14, 2017
Repositioning of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into PracticeAnnalisa Marcuzzi, Claudia Loganes, Claudio Celeghini, et al.
Cellular and Molecular Life Sciences : CMLS|January 15, 2014
NF-κB pathways in hematological malignanciesChiara Gasparini, Claudio Celeghini, Lorenzo Monasta, et al.
Pageof 15